Department of Clinical Epidemiology (DCE)

Aarhus University Seal / Aarhus Universitets segl
You are here: Department of Clinical Medicine » Department of Clinical Epidemiology » Use of the protease inhibitor saquinavir hard gel in huma...

Contact

Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research

Standard

Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome? / Jensen-Fangel, Søren; Pedersen, C.; Nielsen, H.; Tauris, P.; Møller, A.; Sørensen, Henrik Toft; Obel, N.

In: Scandinavian Journal of Infectious Diseases, Vol. 35, 2003, p. 743-749.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research

Harvard

Jensen-Fangel, S, Pedersen, C, Nielsen, H, Tauris, P, Møller, A, Sørensen, HT & Obel, N 2003, 'Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?', Scandinavian Journal of Infectious Diseases, vol. 35, pp. 743-749.

APA

Jensen-Fangel, S., Pedersen, C., Nielsen, H., Tauris, P., Møller, A., Sørensen, H. T., & Obel, N. (2003). Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome? Scandinavian Journal of Infectious Diseases, 35, 743-749.

CBE

Jensen-Fangel S, Pedersen C, Nielsen H, Tauris P, Møller A, Sørensen HT, Obel N. 2003. Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?. Scandinavian Journal of Infectious Diseases. 35:743-749.

MLA

Jensen-Fangel, Søren et al. "Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?". Scandinavian Journal of Infectious Diseases. 2003, 35. 743-749.

Vancouver

Jensen-Fangel S, Pedersen C, Nielsen H, Tauris P, Møller A, Sørensen HT et al. Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome? Scandinavian Journal of Infectious Diseases. 2003;35:743-749.

Author

Jensen-Fangel, Søren ; Pedersen, C. ; Nielsen, H. ; Tauris, P. ; Møller, A. ; Sørensen, Henrik Toft ; Obel, N. / Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?. In: Scandinavian Journal of Infectious Diseases. 2003 ; Vol. 35. pp. 743-749.

Bibtex

@article{01cbf860955e11dabee902004c4f4f50,
title = "Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?",
author = "S{\o}ren Jensen-Fangel and C. Pedersen and H. Nielsen and P. Tauris and A. M{\o}ller and S{\o}rensen, {Henrik Toft} and N. Obel",
year = "2003",
language = "English",
volume = "35",
pages = "743--749",
journal = "Scandinavian Journal of Infectious Diseases",
issn = "0036-5548",
publisher = "Taylor & Francis ",

}

RIS

TY - JOUR

T1 - Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?

AU - Jensen-Fangel, Søren

AU - Pedersen, C.

AU - Nielsen, H.

AU - Tauris, P.

AU - Møller, A.

AU - Sørensen, Henrik Toft

AU - Obel, N.

PY - 2003

Y1 - 2003

M3 - Journal article

VL - 35

SP - 743

EP - 749

JO - Scandinavian Journal of Infectious Diseases

JF - Scandinavian Journal of Infectious Diseases

SN - 0036-5548

ER -